| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.15B | 67.38B | 72.71B | 83.87B | 70.79B | 53.98B |
| Gross Profit | 28.72B | 26.21B | 27.93B | 36.49B | 27.63B | 20.41B |
| EBITDA | 8.77B | 8.73B | 11.17B | 18.49B | 13.83B | 7.81B |
| Net Income | 1.94B | 1.78B | 4.41B | 10.14B | 7.89B | 2.80B |
Balance Sheet | ||||||
| Total Assets | 105.29B | 107.22B | 107.14B | 104.23B | 94.96B | 88.25B |
| Cash, Cash Equivalents and Short-Term Investments | 16.42B | 19.21B | 17.63B | 18.41B | 17.90B | 16.78B |
| Total Debt | 25.03B | 26.22B | 25.24B | 25.49B | 25.49B | 29.13B |
| Total Liabilities | 41.79B | 43.40B | 41.13B | 45.42B | 45.95B | 45.14B |
| Stockholders Equity | 63.50B | 63.81B | 66.01B | 58.81B | 48.97B | 43.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.39B | 3.70B | 4.42B | 7.93B | 4.30B |
| Operating Cash Flow | 0.00 | 11.25B | 5.50B | 7.01B | 9.65B | 7.44B |
| Investing Cash Flow | 0.00 | -4.10B | -1.92B | -3.11B | -1.29B | -3.15B |
| Financing Cash Flow | 0.00 | -2.90B | -4.46B | -4.40B | -8.68B | -3.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥81.20B | 136.93 | 5.02% | 3.23% | -10.00% | -51.92% | |
81 Outperform | ¥239.71B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
76 Outperform | ¥84.88B | 19.06 | ― | 4.45% | 0.59% | -10.60% | |
70 Outperform | ¥134.62B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
69 Neutral | ¥64.04B | 10.78 | 7.00% | 3.02% | 15.78% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥278.18B | 8.88 | 7.67% | 0.91% | 9.03% | 10.76% |